Bio

Nithya brings more than 22 years of experience in pharmaceuticals and biotech operations and executive management, commercializing novel therapies and building start-up organizations. Prior to joining, Nithya was the Chief Operating Officer of SionnaTherapeutics, a company focused on development of novel therapies for Cystic Fibrosis. Prior to this role, she was the Chief Commercial Officer of Rhythm Pharmaceuticals from clinical-stage start-up to approval of their first product. Nithya joined Rhythm from Biogen, where in her 5-year tenure, she oversaw the launches of Alprolix® and Eloctate®. While with Biogen, Nithya also led the Tecfidera® global business and cross-functional strategies for long-term value creation as Vice President and Asset Executive. Nithya began her career with 12 years at Johnson & Johnson Company, launching brands in the US and abroad including: Xarelto®, Levaquin®, Topamax®, Ultracet®, and Velcade®. Ms. Desikan holds a BS in Material Science Engineering from the University of Florida.